<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04905953</url>
  </required_header>
  <id_info>
    <org_study_id>N-128-2020</org_study_id>
    <nct_id>NCT04905953</nct_id>
  </id_info>
  <brief_title>Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache</brief_title>
  <official_title>Comparison Of Different Doses Of Intrathecal Neostigmine In Prevention Of Post-Dural Puncture Headache: Prospective, Randomized, Controlled, Triple-blinded Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Cairo University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Cairo University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      We hypothesized that; intrathecal administration of neostgmine in spinal anesthesia may have&#xD;
      a beneficial role in reduction of the incidence or severity of PDPH.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Neostigmine will be administered in two different doses (10 &amp; 20 mic) in addition to 10mg&#xD;
      bupivicaine intrathecally for cesarean section compared to control group where 10 mg&#xD;
      bupivicaine in addition to 20mic fentanyl will be administered intrathecally. The primary&#xD;
      outcome will be detection of the incidence of postdural puncture headache (PDPH). A 25-gauge&#xD;
      Quincke spinal needle will be used for spinal anesthesia.Patients indicated for elective&#xD;
      caesarean section surgery will be included in the study. The exclusion criteria are&#xD;
      contraindications for regional anesthesia including local infection, hemorrhagic disorders,&#xD;
      drug hypersensitivity, muscular disorders and central and peripheral neuropathy, and drug&#xD;
      abuse history and addiction.&#xD;
&#xD;
      Other outcomes will include age, ASA class, and duration of surgery. Sensory and motor&#xD;
      function will be assessed every minute until T4 level is reached. Hemodynamic status&#xD;
      (systolic and diastolic blood pressures, heart rate, and SPO2) will be recorded every 3&#xD;
      minutes throughout the surgery and then 4 hourly thereafter, for 24 h postoperatively.&#xD;
      Recovery time from spinal anesthesia (return of motor power of both lower limbs) will be also&#xD;
      recorded by anesthesiologist who is unaware of the group. Also the intra-operative and&#xD;
      recovery phase complications including nausea, vomiting, itching, dyspnea, respiratory rate&#xD;
      less than 10 per min, hypoxia (SPO2 less than 92% on room air), bradycardia (HR less than&#xD;
      60bpm), and hypotension (SPB less than 90) will be recorded.&#xD;
&#xD;
      Postoperative assessment will include pain scores &quot;Overall 24-h VAS score&quot;, recorded at&#xD;
      30-min interval for first 4 h and then 4 hourly thereafter, for 24 h postoperatively.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 1, 2021</start_date>
  <completion_date type="Anticipated">May 1, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2022</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The incidence of PDPH following spinal anesthesia for cesarean section surgery.</measure>
    <time_frame>72 hours.</time_frame>
    <description>Diagnosis of PDPH is as follows, it is severe and described as &quot;searing and spreading like hot metal,&quot; involving the back and front of the head, and spreading to the neck and shoulders, sometimes involving neck stiffness.</description>
  </primary_outcome>
  <enrollment type="Anticipated">274</enrollment>
  <condition>Headache</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Neostigmine</intervention_name>
    <description>Intrathecal injection of two doses of neostigmine (10 &amp; 20 mic) during spinal anesthesia for cesarean section.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients indicated for elective caesarean section surgery&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Contraindications for regional anesthesia including local infection, hemorrhagic&#xD;
             disorders, drug hypersensitivity, muscular disorders and central and peripheral&#xD;
             neuropathy, and drug abuse history and addiction.&#xD;
      </textblock>
    </criteria>
    <gender>Female</gender>
    <gender_based>Yes</gender_based>
    <gender_description>Females candidate for elective cesarean section</gender_description>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Shymaa Fathy, MD</last_name>
    <phone>+201000455897</phone>
    <phone_ext>002</phone_ext>
    <email>angel6122003@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine- Cairo University</name>
      <address>
        <city>Cairo</city>
        <zip>11562</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Shymaa Fathy, MD</last_name>
      <phone>23649281</phone>
      <phone_ext>002</phone_ext>
      <email>pg@kasralainy.edu.eg</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <reference>
    <citation>Abdelaal Ahmed Mahmoud A, Mansour AZ, Yassin HM, Hussein HA, Kamal AM, Elayashy M, Elemady MF, Elkady HW, Mahmoud HE, Cusack B, Hosny H, Abdelhaq M. Addition of Neostigmine and Atropine to Conventional Management of Postdural Puncture Headache: A Randomized Controlled Trial. Anesth Analg. 2018 Dec;127(6):1434-1439. doi: 10.1213/ANE.0000000000003734.</citation>
    <PMID>30169405</PMID>
  </reference>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>March 16, 2021</study_first_submitted>
  <study_first_submitted_qc>May 24, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 28, 2021</study_first_posted>
  <last_update_submitted>May 24, 2021</last_update_submitted>
  <last_update_submitted_qc>May 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 28, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Cairo University</investigator_affiliation>
    <investigator_full_name>Shymaa Fathy</investigator_full_name>
    <investigator_title>Lecturer of anesthesia and SICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Post-Dural Puncture Headache</mesh_term>
    <mesh_term>Headache</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Neostigmine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

